GSK, Imagine Institute partner for rare disease

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered with the Imagine Institute to discover and develop compounds to treat Netherton syndrome, a rare inherited skin disorder characterized by chronic skin...